Results 101 to 110 of about 3,507,689 (226)
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT Managing thrombosis in patients with bleeding disorders requires careful assessment of thromboembolic and bleeding risks, tailoring antithrombotic treatment in terms of type, dose, and duration, and considering the need for replacement therapy based on individual factor levels and bleeding history.
Synnøve Gjelsten Mortensen +4 more
wiley +1 more source
Heparin-antithrombin III binding. In vitro and in vivo studies
, 1979 Heparin antithrombin III binding was studied by crossed immunoelectrophoresis. In plasma and purified antithrombin III standard, multicomponent patterns were obtained with low concentrations of mucosal heparin. There is evidence that antithrombin III may
Chan, TK, Chan, V
core
Egyptian Pediatric Association GazetteBackground In critically ill cases, CRRT is a renal replacement intervention. The most common reason why CRRT terminates prematurely (non-electively) is clotting in the extracorporeal circuit, more especially in the filter.
Fatina Ibrahim Fadel +4 more
doaj +1 more source
Clinical Case Reports, Volume 14, Issue 10, October 2026.ABSTRACT This case highlights key laboratory red flags and a failure to respond to standard treatment, both of which should prompt urgent investigation for occult malignancy in patients presenting with cancer‐related microangiopathic hemolytic anemia (CR‐MAHA).
Danijela Jovanovic +4 more
wiley +1 more source
, 1979 Immunoreactive antithrombin III was demonstrated in fresh endothelial cells isolated from human umbilical cord. After a 7 days' culture, antithrombin III was present in the culture medium as well as in the cells.
Chan, TK, Chan, V
core +1 more source
Plasma Exchange for Hantavirus Pulmonary Syndrome: A Mechanistic Case for an Untested Intervention
Journal of Clinical Apheresis, Volume 41, Issue 5, October 2026.ABSTRACT Hantavirus pulmonary syndrome (HPS) carries a case fatality rate of 35%–40% and has no approved pharmacologic treatment. Its pathophysiology is rooted in the plasma compartment: cytokines, viral antigens, immune complexes, and platelet‐binding glycoproteins circulate as drivers of immunopathologic endothelial injury, noncardiogenic pulmonary ...
Menatalla Nadim +2 more
wiley +1 more source
Journal of Rawalpindi Medical College, 2014 Background: To estimate plasma levels of natural anticoagulants, i.e., Protein C, Protein S and Antithrombin III in patients with solid malignancies Methods: A cross-sectional study was conducted wherein plasma levels of Protein C,S and Antithrombin III (
Samina T.Amanat
doaj +2 more sources
Neutrophil Extracellular Traps in Atherosclerosis and Cardiovascular Disease
MedComm, Volume 7, Issue 10, October 2026.NETs as integrated effectors in the atherosclerotic cardiovascular disease continuum. Activated neutrophils release NETs that promote endothelial injury, thrombo‐inflammation, and plaque destabilization throughout atherosclerotic disease progression. Created with BioRender.com.
Ji Zhang +9 more
wiley +1 more source
Proteoglycan Research, Volume 4, Issue 4, October 2026.ABSTRACT Glycosaminoglycans (GAGs) are linear, negatively charged, polysaccharides that mediate a wide variety of biologically critical interactions with proteins, underpinning growth factor signaling, extracellular matrix assembly, and numerous disease processes.
Holly L. Birchenough +5 more
wiley +1 more source
Therapeutic Apheresis and Dialysis, Volume 30, Issue 5, Page 690-697, October 2026.Abstract Introduction This study aims to investigate patient factors affecting the rate of plasma volume target attained in hypertriglyceridemic pancreatitis (HTG‐AP) patients undergoing double filtration plasmapheresis (DFPP). Methods A retrospective analysis of 82 HTG‐AP‐interpreted patients from January 2019 to April 2024 compared target plasma ...
Hui Zhang, Chenqiang Zhu, Yunlong Wu
wiley +1 more source